Study of CM310 in Subjects With Allergic Rhinitis

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2023
This is a multicenter, randomized, double-blind, placebo-controlled phase III clinical study aimed at evaluating the efficacy and safety of CM310 in patients with seasonal allergic rhinitis, and observing the quality of life, PK, PD characteristics, and immunogenicity of subjects.
Epistemonikos ID: be817016ed0ab321a15bf3e46c4ca8f6014dbed3
First added on: May 15, 2024